Refresh
Gainers Losers Sectors Indices Forex Mutual Funds

Announcements  for Aurobindo Pharma Ltd

05:35 PM
Classification Of Unit-I Of Eugia Pharma Specialities Limited, Shameerpet (Our Wholly Owned Subsidiary) As OAI  
10:59 AM
Announcement under Regulation 30 (LODR)-Newspaper Publication  
12:35 PM
Announcement under Regulation 30 (LODR)-Acquisition  
10:42 PM
Financial Results For The Year Ended March 31, 2026.  
09:05 PM
Intimation Of Appointment Of Internal Auditor  
09:02 PM
Appointment Of Secretarial Auditor  
08:53 PM
Announcement under Regulation 30 (LODR)-Cessation  
08:48 PM
Announcement under Regulation 30 (LODR)-Investor Presentation  
08:45 PM
Announcement under Regulation 30 (LODR)-Press Release / Media Release  
07:43 PM
Board Meeting Outcome for Outcome Of Board Meeting  
09:40 PM
Intimation Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015  
10:03 AM
Curateq Biologics Receives CDSCO Marketing Authorisation (Form CT 23) For Bevqolva?? (Bevacizumab Biosimilar)  
07:03 PM
Announcement under Regulation 30 (LODR)-Closure of Buy Back  
03:57 PM
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation  
03:58 PM
Board Meeting Intimation for Consider And Approve Inter Alia, The Standalone & Consolidated Audited Financial Results Of The Company For The Fourth Quarter And Financial Year Ended March 31, 2026  
04:59 PM
Announcement under Regulation 30 (LODR)-Newspaper Publication  
09:08 AM
US FDA Classification Of Unit-VII Of Aurobindo Pharma Limited, As Voluntary Action Indicated (VAI)  
06:08 PM
Intimation Of Resignation Of Dr. Sanjay Chaturvedi, CEO Of Apitoria Pharma Private Limited, Wholly Owned Subsidiary Of The Company  
02:03 PM
Curateq Biologics Secures Health Canada NOC For Bevqolva??? Bevacizumab Biosimilar  
05:01 PM
Announcement under Regulation 30 (LODR)-Change in Management  
04:30 PM
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A  
05:19 PM
Announcement under Regulation 30 (LODR)-Newspaper Publication  
04:00 PM
Letter Of Offer For Buyback Of Up To 54,23,728 Fully Paid-Up Equity Shares Of The Company  
06:31 PM
Announcement under Regulation 30 (LODR)-Press Release / Media Release  
10:37 AM
Announcement under Regulation 30 (LODR)-Press Release / Media Release  
04:01 PM
Expanding Existing CMO Operations With Merck Sharpe & Dohme Singapore Trading Pte. Ltd By Theranym Biologics Private Limited, A Subsidiary Of The Company .  
10:49 AM
Announcement under Regulation 30 (LODR)-Newspaper Publication  
04:20 PM
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018  
04:23 PM
Announcement under Regulation 30 (LODR)-Newspaper Publication  
04:07 PM
Announcement under Regulation 30 (LODR)-Newspaper Publication  
06:29 PM
Announcement under Regulation 30 (LODR)-Press Release / Media Release  
06:24 PM
Announcement under Regulation 30 (LODR)-Press Release / Media Release  
04:04 PM
Announcement under Regulation 30 (LODR)-Press Release / Media Release  
08:51 AM
Intimation Of Record Date For Buyback  
08:35 AM
Transfer Of Company''s Domestic Branded Pharmaceutical Formulation Business To Auropharm Limited, A Wholly Owned Subsidiary Of The Company.,  
08:24 AM
Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors - Buyback Of Shares  
08:37 PM
Board Meeting Intimation for To Consider, Inter Alia, A Proposal For Buyback Of The Fully Paid-Up Equity Shares Of The Company  
05:36 PM
Update On Solar Power Purchase Agreement And Acquisition Upto 26% Stake In Swarnaakshu Solar Power Private Limited.  
12:05 PM
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report  
04:53 PM
Entry Into Marketing And Distribution Agreement For Biosimilars In EU Territories By Curateq Biologics Private Limited  
05:44 PM
Closure of Trading Window  
09:57 AM
Classification Of Unit-V Of Apitoria Pharma Limited, A Wholly Owned Subsidiary Of The Company As VAI By The US FDA  
04:31 PM
Classification Of Unit-II Of Eugia Pharma Specialities Limited, A Wholly Owned Subsidiary Of The Company As OAI By The US FDA  
12:50 PM
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015  
09:44 AM
Classification Of Unit-IV Of APL Healthcare Limited, A Wholly Owned Subsidiary Of The Company As VAI By The US FDA - Reg.,  
01:14 PM
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation  
01:11 PM
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation  
02:40 PM
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation  
12:08 PM
Announcement under Regulation 30 (LODR)-Press Release / Media Release  
12:19 PM
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation  
09:54 AM
Clarification On Media Report, 'Aurobindo Pharma'S P Sarath Chandra Reddy Acquitted In Delhi Liquor Scam Case'.  
06:16 PM
Clarification sought from Aurobindo Pharma Ltd
04:15 PM
Completion Of US FDA Inspection At Unit I Of Eugia Pharma Specialities Ltd  
11:51 AM
Announcement under Regulation 30 (LODR)-Press Release / Media Release  
11:58 AM
Announcement under Regulation 30 (LODR)-Newspaper Publication  
04:33 PM
Announcement under Regulation 30 (LODR)-Acquisition  
02:54 PM
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot  
03:17 PM
Intimation Of Orders Passed By The Goods & Services Tax Department  
01:38 PM
Clarification On News Item Appearing In Https://Www.Ndtvprofit.Com/"  
11:53 AM
Clarification sought from Aurobindo Pharma Ltd
11:17 AM
Announcement under Regulation 30 (LODR)-Earnings Call Transcript  
06:34 PM
Announcement under Regulation 30 (LODR)-Press Release / Media Release  
11:43 AM
Announcement under Regulation 30 (LODR)-Newspaper Publication  
11:51 AM
Announcement under Regulation 30 (LODR)-Newspaper Publication  
10:04 PM
Completion Of US FDA Inspection At Unit-VII Of Aurobindo Pharma Limited, Jedcherla  
06:58 AM
Announcement under Regulation 30 (LODR)-Investor Presentation  
08:05 PM
Announcement under Regulation 30 (LODR)-Restructuring  
08:00 PM
Announcement under Regulation 30 (LODR)-Acquisition  
07:56 PM
Announcement under Regulation 30 (LODR)-Change in Directorate  
07:50 PM
Announcement under Regulation 30 (LODR)-Investor Presentation  
07:48 PM
Announcement under Regulation 30 (LODR)-Press Release / Media Release  
07:36 PM
Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2025  
07:21 PM
Board Meeting Outcome for Outcome Of Board Meeting  
06:22 PM
Completion Of US FDA Inspection At Unit III Of Eugia Pharma Specialities Ltd., A Wholly Owned Subsidiary Of The Company  
12:02 PM
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation  
12:00 PM
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation  
10:27 AM
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation  
10:07 AM
Clarification On Significant Volume Movement In Company'S Shares  
12:37 PM
Clarification sought from Aurobindo Pharma Ltd
11:15 AM
Clarification On Significant Volume Movement In Company'S Shares  
04:43 PM
Board Meeting Intimation for Intimation Of Board Meeting Date  
05:09 PM
Announcement under Regulation 30 (LODR)-Acquisition  
03:19 PM
Curateq Biologics Receives NOC From Health Canada For Its Biosimilar Dyrupeg  
05:16 PM
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation  
12:20 PM
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018  
06:05 PM
Announcement under Regulation 30 (LODR)-Acquisition  
11:15 AM
Announcement under Regulation 30 (LODR)-Updates on Acquisition  
11:54 AM
Curateq Biologics Private Limited, A Wholly Owned Subsidiary Of The Company Has Mutually Agreed To Terminate Its Agreement With Biofactura Inc, USA  
11:59 AM
Closure of Trading Window  
01:28 PM
Announcement under Regulation 30 (LODR)-Acquisition  
10:06 AM
Completion Of US FDA Inspection At Unit-IV Of APL Healthcare Limited, A Wholly Owned Subsidiary Of The Company  
02:33 PM
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation  
05:13 PM
Completion Of US FDA Inspection At Unit-V Of Apitoria Pharma Private Limited, A Wholly Owned Subsidiary Of The Company  
11:13 AM
Announcement under Regulation 30 (LODR)-Newspaper Publication  
12:09 PM
Announcement under Regulation 30 (LODR)-Newspaper Publication  
04:06 PM
Completion Of US FDA Inspection At Unit II Of Eugia Pharma Specialities Ltd., Bhiwadi, A Wholly Owned Subsidiary Of The Company  
11:49 AM
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation  
10:31 AM
Classification Of US FDA Inspection At Unit-I Of Apitoria Pharma Private Limited, A Wholly Owned Subsidiary Of The Company As Voluntary Action Indicated (VAI)  
05:01 PM
Announcement under Regulation 30 (LODR)-Earnings Call Transcript  
02:14 PM
Announcement under Regulation 30 (LODR)-Newspaper Publication  
View announcements for all companies
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2026 Rediff.com